.jpg/jcr:content.jpg)
Bienvenue sur le portail
Campus Sanofi Belgique
Avez-vous déjà un compte sur Campus Sanofi?
Inscrivez-vous pour recevoir des recommandations
personalisées
Articles
2024 ESC Guidelines for the management of chronic coronary syndromes
Felicita Andreotti, Italy; Christiaan J M Vrints, Belgium
Long-Term Efficacy and Safety of Dupixent in Moderate-to-Severe Atopic Dermatitis: 5-Year Open-Label Extension Study Results
Atopic dermatitis (AD) is a chronic inflammatory skin condition that can significantly impact patients' quality of life. Dupixent (dupilumab) has emerged as a treatment for moderate-to-severe AD. This article summarizes the findings of a 5-year open-label extension study (Beck et al, 2024), providing insights into the long-term efficacy and safety profile of Dupixent for dermatologists managing patients with persistent AD.
What is PRALUENT®?
PRALUENT®: a powerful PCSK9i that ticks all the boxes1–4
PRALUENT is a PCSK9i that reduces the levels of LDL-C in the blood.2 It is a fully human IgG1 monoclonal antibody that works by inhibiting the binding of PCSK9 to LDL- receptors. As a result, PRALUENT increases the number of LDL-receptors available to clear LDL, thereby lowering LDL-C levels.2 Elevated LDL-C levels have been significantly associated with cardiovascular disease such as heart attacks and strokes.1
Is Glycemic Control the Key to Preventing Long-term Complications in Type 2 Diabetes?
(Based on the study: Stratton IM, et al. BMJ. 2000;321(7258):405-12).
Acute LDL-C reduction post ACS: Strike early and strike strong: From evidence to clinical practice
A clinical consensus statement of Association for acute cardiovascular care (ACVC), in collaboration with European association of preventive cardiology (EAPC) and the European Society of Cardiology working group on cardiovascular Pharmacotherapy Krychtiuk KA, et al. Eur Heart J Acute Cardiovasc Care. 2022;11(12):939–949.
Éducation
Brainy Briefs
Des vidéos courtes mais percutantes pour rester informé sur les publications à propos de la sclérose en plaques.
DERM 360°
Clinical challenges to achieve long-term disease control within treatment of moderate to severe AD.
DERM 360° Roundtable: Patient Reported Outcome Measures (PROMs) in Clinical Practice
3rd of December 2024
Managing Atopic Dermatitis During Pregnancy and Breastfeeding
A DermTalks Podcast – Atopic Dermatitis in Special Populations. This podcast series is dedicated to exploring the management of atopic dermatitis in specific patient groups.
Speaker : Dr. Klas Agerberg, Uppsala University Hospital, Sweden
Managing Pediatric Atopic Dermatitis
A DermTalks Podcast – Atopic Dermatitis in Special Populations. This podcast series is dedicated to exploring the management of atopic dermatitis in specific patient groups.
Speaker : Dr. Hannah de Leye, UZ Brussel, Belgium
Podcasts
Polyp Gossip
Polyp Gossip is a video podcast dedicated to exploring Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Hosted by two globally recognized rhinologists. The show delves into trending topics, latest advancements, and patient experiences.
The Hematology Podcast
Welcome to The Hematology Podcast, your source for the latest insights into hematology and rare blood disorders. This podcast covers cutting-edge research, clinical advancements, and real-world cases tailored for healthcare professionals.
A heart for Fabry - Podcast
A podcast series designed by cardiologists, for cardiologists and other healthcare professionals.
DermTalks
Are you interested in learning more about managing atopic dermatitis in specific patient groups? Look no further and listen to the DermTalks Podcast - Atopic Dermatitis in Special Populations!
Hot topics in atopic dermatitis
The podcast explores advancements and challenges in managing atopic dermatitis, featuring insights from Dr. Diamant Thaci, a noted expert in inflammation medicine. It discusses the importance of interdisciplinary care and the evolution from general dermatological practice to specialized clinics.
RespTalks
Resptalks is a series of scientific webinars & podcasts on current topics related to respiratory diseases such as asthma, chronic rhinosinusitis with nasal polyps, to type 2 inflammation and much more. They are intended for pulmonologists, ENTs, allergologists, pediatricians, scientists from the Nordics countries and the BeNeLux.
Les contenus accessibles par ce site sont destinés exclusivement aux Professionnels de Santé.
Les contenus accessibles par ce site sont destinés
exclusivement aux Professionnels de Santé.
Sanofi met a votre disposition, sur un portail unique dédié aux professionnels de santé, des contenus exclusifs comprenant des contenus scientifiques et des outils pour votre pratique quotidienne.